Market News AIOpen the app

NAGE stock news · Niagen Bioscience

Stories about Niagen Bioscience (NAGE) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for NAGE

Follow Niagen Bioscience (NAGE) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NAGE
Free on the App Store and Google Play, or on the web.
  1. Nov 7, 2026, 9:57 AM ET · Opinion

    Freedom Broker still thinks Niagen Bioscience is a good buy but cut its price target from $8.50 to $6.

    Neutral

    Niagen Bioscience's price target was cut 29.4%, from $8.50 to $6, but Freedom Broker kept its Buy rating. The mixed call does not change how we read the company.

  2. Nov 7, 2026, 9:57 AM ET · Opinion

    Canaccord Genuity still thinks Niagen Bioscience is a good buy but has cut its price target from $9 to $7.

    Neutral

    Canaccord kept its Buy rating but cut Niagen Bioscience's target 22.2%, from $9 to $7, despite citing possible 232.5% upside. The opposing signals leave its outlook unchanged.